At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02396 B&K CORP-B
Not Yet Opened 01-22 16:08:16
10.570
-0.400
-3.65%
High11.250
Low10.510
Vol156.20K
Open11.250
D1 Closing10.970
Amplitude6.75%
Mkt Cap1.24B
Tradable Cap877.54M
Total Shares117.66M
T/O1.67M
T/O Rate0.19%
Tradable Shares83.02M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
HKEX Announcement Highlights | China Shenhua to Acquire Assets from Parent for ~¥133.6B and Raise Up to ¥20B; B&K Corp-B, Nanhua Futures Among 4 New Listings Tomorrow
B&K Corp Ltd is a China-based company principally engaged in the research and development of biopharmaceutical products. The Company committed to developing therapies with an emphasis on protein drugs for indications with medical needs and market opportunities. The Company primarily focus on the discovery, development and commercialization of therapies for wound healing, currently platelet-derived growth factor (PDGF) drugs. The Company mainly operates its businesses in the domestic market.